182 related articles for article (PubMed ID: 33922198)
1. Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study.
Reinwald M; Deckert PM; Ritter O; Andresen H; Schreyer AG; Weylandt KH; Dammermann W; Lüth S
Healthcare (Basel); 2021 Apr; 9(5):. PubMed ID: 33922198
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.
Alharbi SA; Almutairi AZ; Jan AA; Alkhalify AM
Cureus; 2020 Sep; 12(9):e10285. PubMed ID: 33047077
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.
Hodgson D; Colton H; Hornsby H; Brown R; Mckenzie J; Bradley KL; James C; Lindsey BB; Birch S; Marsh L; Wood S; Bayley M; Dickson G; James DC; Nicklin MJH; Sayers JR; Zafred D; Rowland-Jones SL; Kudesia G; Kucharski A; ; Darton TC; de Silva TI; Collini PJ
medRxiv; 2021 Jul; ():. PubMed ID: 34268521
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.
Musa S; Abdel Alem S; Amer K; Elnagdy T; Hassan WA; Ali MA; Gaber Y; Badary HA; Tantawi O; Abdelmoniem R; Radwan A; Yousof H; Shawky S; Talaat H; Fouad R; Kassem AM
J Infect Public Health; 2021 Oct; 14(10):1466-1473. PubMed ID: 34175238
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.
Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C
BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers.
Cordova E; Bacelar B; Nieto F; Garibaldi F; Aguirre V; Machuca M; Badia M; Rodriguez C
Occup Med (Lond); 2021 Aug; 71(4-5):215-218. PubMed ID: 34008016
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.
Iversen K; Kristensen JH; Hasselbalch RB; Pries-Heje M; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Fischer TK; Juul Jensen CA; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Gybel-Brask M; Dessau RB; Sørensen E; Harritshøj L; Folke F; Sten C; Engel Møller ME; Benfield T; Ullum H; Jørgensen CS; Erikstrup C; Ostrowski SR; Nielsen SD; Bundgaard H
Clin Microbiol Infect; 2022 May; 28(5):710-717. PubMed ID: 34543759
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
[TBL] [Abstract][Full Text] [Related]
12. Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: A multicenter study from Egypt.
El-Sokkary RH; Daef E; El-Korashi LA; Khedr EM; Gad D; Mohamed-Hussein A; Zayed NE; Mostafa EF; Bahgat SM; Hassany SM; Amer MG; El-Mokhtar MA; Elantouny NG; Hassan SA; Zarzour AA; Hashem MK; Amin MT; Hassan HM
J Infect Public Health; 2021 Oct; 14(10):1474-1480. PubMed ID: 34556461
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study.
Bułdak RJ; Woźniak-Grygiel E; Wąsik M; Kasperczyk J; Gawrylak-Dryja E; Mond-Paszek R; Konka A; Badura-Brzoza K; Fronczek M; Golec M; Lejawa M; Markiel M; Kasperczyk S; Brzoza Z
Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33924173
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
[No Abstract] [Full Text] [Related]
15. Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.
Lustig Y; Cohen C; Biber A; Jaber H; Becker Ilany Y; Indenbaum V; Amit S; Mandelboim M; Mendelson E; Regev-Yochay G
Euro Surveill; 2021 Dec; 26(48):. PubMed ID: 34857065
[TBL] [Abstract][Full Text] [Related]
16. [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].
Herrmann BL
MMW Fortschr Med; 2020 Aug; 162(14):44-46. PubMed ID: 32780376
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of IgG against SARS-CoV-2 and its determinants among healthcare workers of a COVID-19 dedicated hospital of India.
Mahto M; Banerjee A; Biswas B; Kumar S; Agarwal N; Singh PK
Am J Blood Res; 2021; 11(1):44-52. PubMed ID: 33796388
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
[TBL] [Abstract][Full Text] [Related]
19. The Longitudinal Analysis on the Anti-SARS-CoV-2 Antibodies among Healthcare Workers in Poland-Before and after BNT126b2 mRNA COVID-19 Vaccination.
Lorent D; Nowak R; Luwański D; Pisarska-Krawczyk M; Figlerowicz M; Zmora P
Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298441
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
